Design Therapeutics (DSGN) Capital Expenditures (2020 - 2021)
Historic Capital Expenditures for Design Therapeutics (DSGN) over the last 2 years, with Q4 2021 value amounting to $354000.0.
- Design Therapeutics' Capital Expenditures rose 242857.14% to $354000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $340000.0 for FY2024, which is 3281.25% up from last year.
- Latest data reveals that Design Therapeutics reported Capital Expenditures of $354000.0 as of Q4 2021, which was up 242857.14% from $968000.0 recorded in Q3 2021.
- In the past 5 years, Design Therapeutics' Capital Expenditures registered a high of $968000.0 during Q3 2021, and its lowest value of $14000.0 during Q4 2020.